Free Trial
Geoff Meacham

Geoff Meacham Analyst Performance

Managing Director / Global Head of Healthcare at Citigroup

Geoff Meacham is a stock analyst at Citigroup focused in the healthcare sector, covering 48 publicly traded companies. Over the past year, Geoff Meacham has issued 94 stock ratings, including buy, hold, and sell recommendations. While full access to Geoff Meacham's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Geoff Meacham's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
218 Last 11 Years
Buy Recommendations
60.28% 129 Buy Ratings
Companies Covered
48 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.9%1 ratings
Buy59.3%127 ratings
Hold35.0%75 ratings
Sell4.7%10 ratings

Out of 214 total stock ratings issued by Geoff Meacham at Citigroup, the majority (59.3%) have been Buy recommendations, followed by 35.0% Hold, 4.7% Sell, and 0.9% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
83.3% of companies on NASDAQ
40 companies
NYSE
16.7% of companies on NYSE
8 companies

Geoff Meacham, an analyst at Citigroup, currently covers 48 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
47 companies
97.9%
Miscellaneous
1 company
2.1%

Geoff Meacham of Citigroup specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
36 companies
75.0%
PHARMACEUTICALS
11 companies
22.9%
Miscellaneous
1 company
2.1%

Geoff Meacham's Ratings History at Citigroup

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
11/10/2026Boost Price Target$12.24$60.00Buy
Veradermics, Incorporated stock logo
MANE
Veradermics
11/10/2026Boost Price Target$148.72$175.00Buy
Iambic Therapeutics, Inc. stock logo
IAM
Iambic Therapeutics
11/9/2026Initiated Coverage$10.17$22.00Buy
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
11/5/2026Boost Price Target$67.60$78.00Buy
Amgen Inc. stock logo
AMGN
Amgen
11/4/2026Boost Price Target$478.54$465.00Neutral
Pfizer Inc. stock logo
PFE
Pfizer
11/4/2026Boost Price Target$30.79$30.00Neutral
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
10/30/2026Downgrade$0.21$1.00Hold
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/30/2026Boost Price Target$170.68$188.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/30/2026Boost Price Target$1,415.64$1,650.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/30/2026Boost Price Target$927.89$825.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
10/28/2026Reiterated Rating$245.98Neutral
Moderna, Inc. stock logo
MRNA
Moderna
10/23/2026Reiterated Rating$202.63Sell
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
10/19/2026Reiterated Rating$4.44Market Outperform
Novavax, Inc. stock logo
NVAX
Novavax
10/15/2026Reiterated Rating$12.64$8.00Sell
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
10/15/2026Boost Price Target$27.82$39.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
10/12/2026Boost Price Target$145.49$145.00Neutral
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
10/5/2026Boost Price Target$107.39$150.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
9/30/2026Downgrade$203.46$80.00Sell
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
9/30/2026Initiated Coverage$232.35$325.00Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
9/30/2026Initiated Coverage$5.64$12.00Buy
Veradermics, Incorporated stock logo
MANE
Veradermics
9/15/2026Reiterated Rating$101.36Buy
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
9/15/2026Boost Price Target$2.79$5.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
9/14/2026Boost Price Target$55.41$74.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
9/8/2026Reiterated Rating$256.27Buy
AbbVie Inc. stock logo
ABBV
AbbVie
9/8/2026Boost Price Target$266.38$282.00
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
8/31/2026Boost Price Target$146.69$182.00Buy
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
8/31/2026Reiterated Rating$147.75Outperform
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
8/11/2026Boost Price Target$84.75$104.00Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
8/7/2026Boost Price Target$52.64$60.00Buy
Amgen Inc. stock logo
AMGN
Amgen
8/7/2026Boost Price Target$404.85$405.00Neutral
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
8/6/2026Boost Price Target$146.11$175.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
8/5/2026Lower Price Target$91.84$125.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
8/3/2026Boost Price Target$54.82$60.00Neutral
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
8/3/2026Reiterated Rating$65.44$70.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
8/3/2026Boost Price Target$202.95$215.00Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/3/2026Boost Price Target$760.99$740.00Neutral
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
8/3/2026Boost Price Target$20.23$26.00Buy
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
7/29/2026Boost Price Target$79.45$100.00Buy
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
7/17/2026Reiterated Rating$132.02Outperform
Veradermics, Incorporated stock logo
MANE
Veradermics
7/16/2026Boost Price Target$124.16$160.00Buy
Your free book is about to disappear (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/15/2026Boost Price Target$1,154.27$1,600.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
7/15/2026Boost Price Target$244.75$260.00Neutral
AbbVie Inc. stock logo
ABBV
AbbVie
7/10/2026Boost Price Target$246.34$276.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/23/2026Downgrade$132.76$135.00Neutral
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/22/2026Downgrade$132.55Hold
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
6/10/2026Boost Price Target$25.94$42.00Buy
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
6/9/2026Upgrade$70.87$108.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/18/2026Downgrade$698.25$700.00Neutral
Veradermics, Incorporated stock logo
MANE
Veradermics
5/18/2026Boost Price Target$100.35$135.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
5/15/2026Lower Price Target$5.84$14.00Buy
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
5/7/2026Boost Price Target$50.20$66.00Buy
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
5/6/2026Reiterated Rating$99.21Outperform
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
5/6/2026Initiated Coverage$113.73$125.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
5/1/2026Boost Price Target$189.28$200.00Neutral
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
5/1/2026Boost Price Target$59.18$66.00
Pfizer Inc. stock logo
PFE
Pfizer
4/29/2026Boost Price Target$26.45$27.00Neutral
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
4/29/2026Boost Price Target$53.27$60.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/13/2026Lower Price Target$173.61$190.00Neutral
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4/13/2026Boost Price Target$137.70$165.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
3/27/2026Boost Price Target$7.49$16.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
3/24/2026Boost Price Target$73.35$125.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
3/20/2026Boost Price Target$113.62$125.00Neutral
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
3/19/2026Boost Price Target$103.71$125.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
3/11/2026Lower Price Target$60.89$85.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2026Lower Price Target$90.85$130.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
3/10/2026Boost Price Target$502.67$585.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
3/6/2026Reiterated Rating$144.40Buy
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3/4/2026Boost Price Target$45.78$58.00Buy
Veradermics, Incorporated stock logo
MANE
Veradermics
3/2/2026Initiated Coverage$45.70$85.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
3/2/2026Boost Price Target$89.87$120.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/24/2026Downgrade$113.75$115.00Neutral
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
2/20/2026Boost Price Target$14.02$19.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
2/16/2026Reiterated Rating$42.23Neutral
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$196.18$215.00Neutral
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/6/2026Boost Price Target$61.82$64.00Neutral
Amgen Inc. stock logo
AMGN
Amgen
2/4/2026Boost Price Target$338.59$345.00Neutral
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2/4/2026Boost Price Target$119.57$120.00Neutral
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
1/27/2026Boost Price Target$40.47$50.00Buy
Biogen Inc. stock logo
BIIB
Biogen
1/27/2026Boost Price Target$173.12$185.00Neutral
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/27/2026Boost Price Target$137.78$156.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1/27/2026Boost Price Target$108.01$115.00Neutral
AbbVie Inc. stock logo
ABBV
AbbVie
1/27/2026Lower Price Target$225.01$230.00Neutral
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
1/22/2026Lower Price Target$60.66$89.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
1/19/2026Reiterated Rating$41.83Neutral
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
1/9/2026Initiated Coverage$41.67$55.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
1/9/2026Initiated Coverage$12.78$50.00Buy
Biogen Inc. stock logo
BIIB
Biogen
1/7/2026Boost Price Target$182.61$180.00Neutral
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/7/2026Boost Price Target$123.45$140.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1/7/2026Boost Price Target$108.78$110.00Neutral
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/9/2025Boost Price Target$94.30$110.00Buy
What the hell is going on? (Ad)

Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel

Watch Porter Stansberry's full broadcast on the coming dollar reset now
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
12/8/2025Boost Price Target$89.65$115.00Buy
Pfizer Inc. stock logo
PFE
Pfizer
12/2/2025Initiated Coverage$25.31$26.00Neutral
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
12/2/2025Lower Price Target$33.99$49.00Buy
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
11/18/2025Lower Price Target$1.64$8.00Buy
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
11/10/2025Boost Price Target$83.23$98.00Buy
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
11/5/2025Boost Price Target$67.72$75.00Neutral
AbbVie Inc. stock logo
ABBV
AbbVie
11/3/2025Lower Price Target$218.14$235.00Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/29/2025Boost Price Target$652.98$700.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/27/2025Downgrade$69.99Hold
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/27/2025Reiterated Rating$49.15$72.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
10/23/2025Lower Price Target$26.85$28.00Neutral
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
10/17/2025Boost Price Target$75.73$96.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
10/17/2025Boost Price Target$36.47$50.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
10/17/2025Boost Price Target$60.46$80.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
10/17/2025Boost Price Target$68.43$93.00Buy
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
10/17/2025Boost Price Target$37.92$50.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
10/17/2025Boost Price Target$14.59$20.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
10/13/2025Initiated Coverage$86.02$95.00Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/13/2025Boost Price Target$553.05$660.00Buy
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/8/2025Boost Price Target$116.78$135.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
10/3/2025Boost Price Target$13.29$16.00Buy
AbbVie Inc. stock logo
ABBV
AbbVie
10/3/2025Boost Price Target$237.22$251.00Neutral
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
10/2/2025Boost Price Target$408.38$575.00Buy
Biogen Inc. stock logo
BIIB
Biogen
9/24/2025Reiterated Rating$137.38Neutral
Amgen Inc. stock logo
AMGN
Amgen
9/24/2025Boost Price Target$286.81$315.00Neutral
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
9/15/2025Boost Price Target$40.52$65.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
8/28/2025Boost Price Target$9.47$14.00Buy
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
8/27/2025Upgrade$4.44$14.00Buy
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
8/25/2025Lower Price Target$1.51$9.00Buy
Amgen Inc. stock logo
AMGN
Amgen
8/6/2025Boost Price Target$284.67$310.00Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/1/2025Reiterated Rating$545.46$650.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
8/1/2025Initiated Coverage$29.56$40.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
8/1/2025Boost Price Target$131.95$135.00Neutral
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/28/2025Boost Price Target$44.96$50.00Neutral
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
7/22/2025Boost Price Target$35.64$42.00Buy
Amgen Inc. stock logo
AMGN
Amgen
7/22/2025Boost Price Target$302.13$305.00Neutral
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
7/22/2025Lower Price Target$64.51$78.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
7/7/2025Reiterated Rating$39.24Buy
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
6/25/2025Boost Price Target$44.79$54.00Buy
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
6/17/2025Initiated Coverage$54.66$72.00Buy
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
6/17/2025Initiated Coverage$19.75$42.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
6/17/2025Initiated Coverage$64.09$110.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
6/17/2025Initiated Coverage$5.44$12.00Buy
Acumen Pharmaceuticals, Inc. stock logo
ABOS
Acumen Pharmaceuticals
6/17/2025Initiated Coverage$1.14$4.00Buy
Novavax, Inc. stock logo
NVAX
Novavax
6/17/2025Initiated Coverage$7.03$6.00Sell
AbbVie Inc. stock logo
ABBV
AbbVie
6/11/2025Boost Price Target$191.43$205.00Hold
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
6/10/2025Boost Price Target$32.66$75.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
6/9/2025Boost Price Target$33.43$54.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
6/2/2025Lower Price Target$486.45$650.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/14/2025Upgrade$574.16$700.00Buy
What the hell is going on? (Ad)

Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel

Watch Porter Stansberry's full broadcast on the coming dollar reset now
AbbVie Inc. stock logo
ABBV
AbbVie
5/14/2025Reiterated Rating$187.95$205.00Neutral
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
5/12/2025Lower Price Target$31.92$44.00Neutral
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
5/7/2025Upgrade$36.19$40.00Neutral
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/6/2025Reiterated Rating$101.10$140.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
4/2/2025Reiterated Rating$0.91$1.00Underperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
3/13/2025Initiated Coverage$38.53$95.00Buy
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/13/2025Initiated Coverage$100.31$145.00Buy
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
3/13/2025Initiated Coverage$22.50$40.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
3/13/2025Initiated Coverage$32.61$70.00Buy
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
3/13/2025Initiated Coverage$35.10$52.00Buy
Moderna, Inc. stock logo
MRNA
Moderna
3/13/2025Initiated Coverage$35.01$40.00Neutral
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
3/10/2025Lower Price Target$30.22$48.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/20/2025Boost Price Target$65.61$103.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$135.56$145.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
2/12/2025Set Price Target$140.64$160.00
Amgen Inc. stock logo
AMGN
Amgen
2/5/2025Reiterated Rating$303.01Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
1/28/2025Lower Price Target$684.71$750.00Neutral
Biogen Inc. stock logo
BIIB
Biogen
1/28/2025Lower Price Target$148.76$160.00Neutral
Amgen Inc. stock logo
AMGN
Amgen
1/28/2025Lower Price Target$282.95$295.00Neutral
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
1/14/2025Lower Price Target$716.90$795.00Neutral
Amgen Inc. stock logo
AMGN
Amgen
11/27/2024Lower Price Target$280.01$310.00